Patritumab plus Erlotinib in EGFR Wild-Type Advanced Non Small Cell Lung Cancer (NSCLC): Part a Results of HER3-Lung Study
JOURNAL OF THORACIC ONCOLOGY（2017）
关键词
non-small cell lung cancer,Heregulin,Patritumab,Phase 3
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要